Physician

Douglas Adam Perry, M.D.

According to 2025 Medicare claims, Douglas Perry, M.D. (NPI: 1306844121) practices internal medicine in the Savannah, GA market, with the plurality of this provider's patient population coming from Bryan, GA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP OF GEORGIA LLC (NPI: 1013313857; TIN: 202265068) and primary practice location at 31324-7661. Perry is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236), participating under the MSSP model.

Perry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 367 traditional Medicare patients, billed 15,493 HCPCS/CPT codes, and received $286,606 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,752 prescription claims across 586 beneficiaries totaling $980,591 in drug costs, led by Ozempic (Semaglutide). DME data shows 71 claims. Open Payments data shows 99 records totaling $1,637. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $218,845 to $286,606. Similarly, Part D prescription costs have risen steadily, from $471,234 to $980,591. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $7,977 to $15,556.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	378	11,540	$218,845
2016	407	10,262	$199,275
2017	467	10,274	$193,749
2018	483	10,683	$199,958
2019	484	10,775	$246,587
2020	412	9,876	$383,150
2021	640	13,043	$229,603
2022	589	18,585	$273,176
2023	340	13,860	$260,937
2024	367	15,493	$286,606

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	368	7,750	$471,234
2016	417	7,885	$481,828
2017	447	8,177	$514,515
2018	440	7,415	$508,817
2019	436	6,967	$516,178
2020	435	7,291	$541,986
2021	453	7,598	$578,859
2022	470	7,916	$640,249
2023	478	8,609	$830,664
2024	586	9,752	$980,591

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	231	$9,054
2016	38	113	$1,293
2017	14	52	$882
2018	12	44	$532
2019	N/R	38	$476
2020	N/R	54	$3,804
2021	N/R	50	$4,962
2022	N/R	74	$8,357
2023	N/R	90	$12,474
2024	N/R	71	$14,241

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	322	994	$77
80061	Blood test, lipids (cholesterol and triglycerides)	311	697	$13
80053	Blood test, comprehensive group of blood chemicals	308	726	$10
36415	Insertion of needle into vein for collection of blood sample	322	835	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	311	734	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	100	4,122	$123,306
Farxiga	Dapagliflozin Propanediol	92	5,130	$92,738
Mounjaro	Tirzepatide	60	1,910	$70,035
Rybelsus	Semaglutide	31	1,470	$45,838
Jardiance	Empagliflozin	38	2,130	$42,015

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	46	$13,792
K0001	Standard wheelchair	Y	N/R	25	$449

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	99	$1,637	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Douglas Adam Perry, M.D.?

Tedicare shows public-source Medicare data for Douglas Adam Perry, M.D. (NPI 1306844121), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas Adam Perry, M.D. have ACO affiliation data?

Douglas Adam Perry, M.D. is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236).

What billing organization is linked to Douglas Adam Perry, M.D.?

Douglas Adam Perry, M.D. is linked to PRIVIA MEDICAL GROUP OF GEORGIA LLC (billing NPI 1013313857) in the available physician profile data.

Does Douglas Adam Perry, M.D. have Open Payments data?

Douglas Adam Perry, M.D. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.